- We will send in 10–14 business days.
/images/books/13454786/9783954892419.jpg)
- Author: Bernt-Dieter Huismans
- Publisher: Anchor Academic Publishing
- Year: 2014
- Pages: 32
- ISBN-10: 3954892413
- ISBN-13: 9783954892419
- Format: 14.8 x 21 x 0.2 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease (e-book) (used book) | bookbook.eu
Reviews
Description
We examined a sample of 90 individuals that had previously received a course of appropriate antibiotics for Lyme disease without experiencing full resolution of their symptoms and had evidence of persistent infection documented by PCR analysis. Mean duration of symptoms was 9.5 years (range 1 - 40 years). The treatment was adapted to the individual case according to clinical response. Long term antibiotic therapy was initiated and patients were treated continuously for at least 6 months, in some cases several years of intermittent therapy was administered. About 38.8% of the patients experienced full remission of symptoms while about 56.7% reported a significant improvement, 5.6% of patients were deemed refractory to therapy. Therapeutic modalities are discussed in detail.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 18d.22:02:07
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Bernt-Dieter Huismans
- Publisher: Anchor Academic Publishing
- Year: 2014
- Pages: 32
- ISBN-10: 3954892413
- ISBN-13: 9783954892419
- Format: 14.8 x 21 x 0.2 cm, softcover
- Language: English English
We examined a sample of 90 individuals that had previously received a course of appropriate antibiotics for Lyme disease without experiencing full resolution of their symptoms and had evidence of persistent infection documented by PCR analysis. Mean duration of symptoms was 9.5 years (range 1 - 40 years). The treatment was adapted to the individual case according to clinical response. Long term antibiotic therapy was initiated and patients were treated continuously for at least 6 months, in some cases several years of intermittent therapy was administered. About 38.8% of the patients experienced full remission of symptoms while about 56.7% reported a significant improvement, 5.6% of patients were deemed refractory to therapy. Therapeutic modalities are discussed in detail.
Reviews